Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study-Reference-Cited by-同舟云学术

Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study

Published:2009-04 Issue:4 Volume:20 Page:655-659
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Mustacchi G.,Mansutti M.,Sacco C.,Barni S.,Farris A.,Cazzaniga M.,Cozzi M.,Dellach C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/4/655/539259/mdn687.pdf

Reference39 articles.

1. NORA Study Group. Adjuvant systemic treatment of early breast cancer: the NORA study;Cazzaniga;Ann Oncol,2006

2. Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial;Mustacchi;Ann Oncol,2003

3. Neoadjuvant endocrine therapy for locally advanced breast cancer;Ma;Semin Oncol,2006

4. Proliferation marker Ki-67 in early breast cancer;Urruticoechea;J Clin Oncol,2005

5. Tamoxifen versus surgery plus tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the “GRETA” and “CRC” trials;Mustacchi;Proc Am Soc Clin Oncol,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinatorial chemosensitive Nanomedicine approach for the treatment of Breast cancer;Current Molecular Medicine;2022-08-19

2. Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events;Dermatology and Therapy;2020-01-21

3. New agents for endocrine resistance in breast cancer;The Breast;2017-08

4. Endocrine treatment in breast cancer: Cure, resistance and beyond;Cancer Treatment Reviews;2016-11

5. The role of preoperative systemic treatment in patients with breast cancer;Współczesna Onkologia;2016